Peripheral arterial occlusive disease (PAOD) is common in older age. PAOD is associated with an increased risk of vascular events (eg, myocardial infarction or stroke). Therefore, the prevention and treatment of PAOD is important, especially at a time when the elderly population is increasing. There is an association between lipid abnormalities and the risk of developing PAOD. However, it is not yet definitively established that early intervention with lipid-lowering drugs prevents the development of PAOD. There is evidence that vascular events in patients with PAOD can be significantly reduced by statins and that the symptoms associated with PAOD are improved by this treatment. There is an urgent need for appropriately designed lipid-lowering trials in patients with PAOD.
Get full access to this article
View all access options for this article.
References
1.
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo controlled trial. Lancet360:7-22, 2002.
2.
Herbert PR, Gaziano JM, Chan KS, et al: Cholesterol lowering with statin drugs, risk of stroke and total mortality. JAMA287:313-321, 1997.
3.
Fayad ZA, Fuster V: Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res89:305-316, 2001.
4.
Hooi JD, Kester AD, Stoffers HE, et al: Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study. Am J Epidemiol153:666-672, 2001.
CAPRIE Steering Committee: A randomised, blinded trial of Clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet348:1329-1339, 1996.
7.
Binaghi F, Fronteddu PF, Cannas F, et al: Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population. Int Angiol13:233-245, 1994.
8.
Drexel H, Steuer J, Muntwyler J, et al: Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation94:199-205, 1996.
9.
Buchwald H, Varco RL, Matts JP, et al: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med323:946-955, 1990.
10.
Blankenhorn DH, Azen SP, Crawford DW, et al: Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation83:438-447, 1991.
11.
Pedersen TR, Kjekshus J, Pyörälä K, et al: Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study. Am J Cardiol81:333-335, 1998.
12.
Salonen R, Nyyssonen K, Porkkala E, et al: Kuopio atherosclerosis prevention study (KAPS). Circulation92:1758-1764, 1995.
13.
Youssef F, Seifalian AM, Jagroop IA, et al: The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg23:358-364, 2002.
14.
McDermott MM, Guralnik JM, Greenland P, et al: Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation107:757-761, 2003.
15.
Dormandy J, Heek L, Vig S: Predictors of early disease in the lower limbs. Semin Vasc Surg12:109-117, 1999.
16.
Clement DL: Medical treatment of peripheral artery occlusive disease. Acta Chir Belg100:190-193, 2000.
17.
National Cholesterol Education Program Expert Panel: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA285:2486-2497, 2001.
18.
Aronow WS, Ahn C: Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol90:789-791, 2002.
19.
Meade T, Zuhrie R, Cook C, et al: Bezafibrate in men with lower extremity arterial disease: Randomised controlled trial. BMJ325:1139-1143, 2002.
20.
Meijer WT, Hoes AW, Rutgers D, et al: Peripheral arterial disease in the elderly. The Rotterdam Study. Arterioscler Thromb Vasc Biol18:185-192, 1998.
21.
Ness J, Aronow WS, Ahn C: Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc48:312-314, 2000.
22.
Athyros VG, Papageorgiou AA, Elisaf M, et al: Statins and renal function in patients with diabetes mellitus. Curr Med Res Opin19:615-617, 2003.
23.
Elisaf M, Mikhailidis DP: Statins and renal function. Angiology53:493-502, 2002.
